Medtech grants in France

Between cycles

Funds early-stage deep tech startups developing solutions at TRL 4-5 in collaboration with industry partners through a 4-month co-creation programme.

Between cycles

Runs research teams and institutions for EIT Health Catapult Edition in biotechnology, medical technology, and artificial intelligence.

Between cycles

Supports international consortia so small companies can turn joint innovation into export-ready products.

Between cycles

Offers market-feasibility support for small companies exploring non-European markets through Europe-wide innovation networks.

Between cycles

Offers European health founders early support from EIT Health through mentorship, networks, and commercialization guidance.

Funds clinical trials of prophylactic vaccines against neglected tropical diseases such as schistosomiasis, leishmaniasis and leprosy in sub-Saharan Africa.

Closed

Funds early clinical trials of therapies built from the molecules cells secrete rather than the cells themselves, aiming for an off-the-shelf alternative to cell therapy.

Funds a flagship project that federates EU health data and pilots AI tools for cardiovascular risk prediction, prevention and personalised care.

Funds AI teams building generative-AI tools for clinical-dataset enhancement or automotive crash-test case generation, paying up to €100,000 in prizes after an initial €28,500 concept-stage award.

Closed

Pays cash prizes to teams that build and validate generative AI solutions for enhancing clinical datasets or generating automatic test cases from crash databases.

Funds one project to build AI algorithms, data-source guidance and practical tools for faster, more accurate detection of drug safety signals.

Closed

Funds research into unmanned vehicles that can find, assess and evacuate wounded soldiers in mass-casualty and CBRN combat zones.

Closed

Funds wearable devices and apps, paired with behavioural coaching, that help 12-to-25-year-olds build habits that prevent the most common non-cancer chronic diseases later in life.

Closed

Pays 200,000 euros to study bioengineering business ideas that use microgravity.

Closed

Funds small, SME-majority consortia running an early-phase clinical trial to move a biotech therapy, from antibodies to RNA therapies, from the lab towards the market.

Funds public-private research on the determinants of health, from prevention and early diagnosis to new vaccine strategies and disease-outbreak preparedness.

Funds public-private research on new health technology assessment methods that value combined, integrated healthcare innovations fairly.

Funds public-private research that makes integrated healthcare solutions feasible and better matched to what patients and citizens actually need.

Funds public-private research that connects fragmented health R&I efforts into shared tools, data, platforms and manufacturing processes.

Funds public-private research on interoperable health data and AI analytics that speed up diagnosis, treatment and personalised care.

Funds a stepwise rollout of gastric cancer screening programmes across EU Member States, including AI-assisted screening.

Closed

Funds research and low-carbon medical technology that cuts the health sector's own emissions while making healthcare systems and communities more resilient to climate change.

Funds pilot projects that assess hospital cybersecurity gaps and demonstrate detection and response tools at partner healthcare sites in at least two member states.

Closed

Funds deployment and clinical validation of multi-modal AI-based medical-imaging tools built on the EU's Cancer Image Europe data platform.